When a patient in an early-phase drug trial experiences a serious side effect today, weeks or even months can pass before ...

AI could "give the scientific community a way to address the most difficult and urgent questions in human health," argues ...

Physiologists have known for years that the biggest nightly growth-hormone pulse lines up with early slow-wave sleep, usually ...

Syncromune ®, Inc., a clinical-stage biopharmaceutical company advancing SYNC-T™, an investigational platform combination immunotherapy for metastatic solid tumor cancers, today presented an oral ...

Regeneron hauled in $3.6 billion during the first quarter of 2026, as analysts homed in on a slight Eylea HD miss and key ...

EVERSANA, a purpose-built, partner-led commercial organization, positions Candel for potential U.S. commercial launch following planned BLA ...

Brief brisk walking breaks during prolonged sitting improved post-meal interstitial glucose responses in healthy adults after ...

As NIH cuts and HR-1 threaten AMCs, Kevin Mahoney, CEO of Penn Medicine and Amy Perry, CEO of Banner Health will keep funding research.

Ladies and gentlemen, good morning, and welcome to the Teradyne First Quarter 2026 Earnings Conference Call. [Operator Instructions] As a reminder, today's call is being recorded. I'd now like to turn ...

NINGDE, China, April 28, 2026 /PRNewswire/ -- On April 27, CATL and HyperStrong signed a strategic cooperation agreement on sodium-ion batteries for energy storage in Ningde, Fujian. The two parties ...

Q4 2025 Earnings Call April 28, 2026 8:00 AM EDTCompany ParticipantsJan Keppeler - Head of Investor Relations, Sustainability ...

A cancer patient enrolled in a clinical trial today might wait months before regulators ever see the safety data generated by ...